Quest Diagnostics Revenue and Competitors

Secaucus, NJ USA

Location

$48.1M

Total Funding

Estimated Revenue & Valuation

  • Quest Diagnostics's estimated annual revenue is currently $11.1B per year.(i)
  • Quest Diagnostics's estimated revenue per employee is $402,360
  • Quest Diagnostics's total funding is $48.1M.
  • Quest Diagnostics's current valuation is $17.5B. (January 2022)

Employee Data

  • Quest Diagnostics has 27463 Employees.(i)
  • Quest Diagnostics grew their employee count by 4% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.1M40-5%N/AN/A
#2
$275.2M72828%N/AN/A
#3
$29.7M10310%N/AN/A
#4
$11050M274634%$48.1MN/A
#5
$15.8M5821%N/AN/A
#6
$16.5M542%N/AN/A
#7
$27.8M72-10%N/AN/A
#8
$21.9M6910%N/AN/A
#9
$10.8M5415%N/AN/A
#10
$10.4M35-5%N/AN/A
Add Company

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. The company reported 2014 revenues of $7.4 billion. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company's approximately 2,200 patient service centers. On a typical workday, testing is performed for about 550,000 patients. Quest Diagnostics empowers healthcare organizations & clinicians with state-of-the-art connectivity solutions. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world's 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination

keywords:N/A

$48.1M

Total Funding

27463

Number of Employees

$11.1B

Revenue (est)

4%

Employee Growth %

$17.5B

Valuation

N/A

Accelerator

Quest Diagnostics's People

NameTitleEmail/Phone
1
Executive Sales Director - South RegionReveal Email/Phone
2
Manager - Process Improvement, Esoteric -Health Systems OperationsReveal Email/Phone
3
IT Manager - Enterprise Systems SupportReveal Email/Phone
4
Six Sigma Black BeltReveal Email/Phone
5
Senior Leadership Team- Manager Business ProcessesReveal Email/Phone
6
Senior IT Project ManagerReveal Email/Phone
7
Administrative AssistantReveal Email/Phone
8
Director - Clinical Trials, Healthcare Analytics SolutionsReveal Email/Phone
9
ExaminerReveal Email/Phone
10
Director ToxicologyReveal Email/Phone

Quest Diagnostics News

2022-04-17 - Quest Diagnostics announces organizational changes to ...

Quest Diagnostics announces organizational changes to accelerate growth, drive operational excellence. By. Linda Lindner(Secaucus). -. April 25,...

2022-04-13 - Quest Diagnostics Q1 2022 Earnings Preview

Quest Diagnostics (NYSE:DGX) is scheduled to announce Q1 earnings results on Thursday, April 21st, before market open.

2022-04-13 - Quest Diagnostics Reports First Quarter 2022 Financial ...

SECAUCUS, N.J., April 21, 2022 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic...

2021-11-24 - Quest Diagnostics Incorporated : Media Statement about COVID-19 Testing

This is an evolving situation. Please check back to this page periodically for the latest information. To receive these media updates, please email mediacontact@questdiagnostics.com. B-Roll and Photos: Testing: https://app.box.com/s/djpwi9bt8bwnaptdvvvtxkgotszvw0hp Self Collection Kit: https: ...

2021-11-10 - Quest Diagnostics Media Statement about COVID-19 Testing

This is an evolving situation. Please check back to this page periodically for the latest information. To receive these media updates, please email mediacontact@questdiagnostics.com. B-Roll and Photos: Testing: https://app.box.com/s/djpwi9bt8bwnaptdvvvtxkgotszvw0hp Self Collection Kit: https: ...